Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

JTV 519

Next Previous
X
Search
Drug Profile

JTV 519

Alternative Names: JTV-519; K201 - Merck; K201 - Sequel

Latest Information Update: 19 Aug 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aetas Pharma; Japan Tobacco
  • Developer Sequel Pharmaceuticals
  • Class Small molecules; Thiazepines
  • Mechanism of Action Calcium channel antagonists; Potassium channel antagonists; Protein kinase C stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Atrial fibrillation; Cancer; Heart failure; Myocardial infarction

Most Recent Events

  • 13 May 2011 Sequel Pharmaceuticals terminates phase II trial in Atrial fibrillation in Denmark and Israel (NCT01259622)
  • 13 May 2011 Sequel Pharmaceuticals terminates phase II trial in Atrial fibrillation in US and EU (NCT01067833)
  • 12 Sep 2007 NovaCardia has been acquired by Merck and Co

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top